16 h. ago Mundipharma announces patient enrolment completion in Phase III ReSPECT clinical trial for REZZAYO® (rezafungin)

For Trade and Medical Media Only Enrolment completed in Phase III ReSPECT study in prophylaxis of fungal infections in adult patients undergoing allogeneic blood and marrow transplant Topline results from ReSPECT study expected by mid-2026 CAMBRIDGE, England — Mundipharma today announced completion of patient enrolment for the ongoing, global Phase III ReSPECT trial evaluating REZZAYO® […]

Science

32 h. ago Plan to demolish Toronto mall for huge condo development falls flat after no one buys

One of the numerous Toronto-area shopping centres on track to be converted into a sprawling condo development has suddenly been left in limbo after the companies involved found themselves unable to sell enough units to justify construction.The 1956-built Cloverdale Mall at Highway 427 and the QEW was one of the first in a growing pack of "dying malls" in and around Toronto whose valuable properties are being reconsidered for use as high-density housing. A plan tabled in 2020 imagined 4,050 units along with tons of retail and community space across the 12-hectare site, and, over the years, the vision has been updated with a more modern, refined design for a complete neighbourhood.But, the first phase of the project, called Clove condos, has just come crashing down at the final hour in light of the present housing market, with virtually no one willing to buy in. Less than 10 per cent of the site's thousands of homes managed to pre-...

Sport

35 h. ago Aecon partnership reaches financial close on the Port of Montreal Expansion in

TORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) — Aecon Group Inc. (TSX: ARE) (“Aecon”) announced today that Contrecoeur Terminal Constructors General Partnership, comprised of Aecon (40%) and Pomerleau (60%), has completed the collaborative development phase and reached financial close on a design-build contract with the Montreal Port Authority for the Port of Montreal Expansion in-water works […]

Culture

8 d. ago First phase of ‘major advancement’ at St. Boniface Hospital now open

The hospital's president and CEO, Nicole Aminot, called the completion of the first phase a major milestone in St. Boniface's history.

Politics

2 w. ago Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones

– Successfully completed enrollment of 36 participants in Phase 2 study of CYB004, the Company’s deuterated dimethyltryptamine (“DMT”) program for the treatment of Generalized Anxiety Disorder (“GAD”). Topline data expected Q1 2026 – – Continues to advance CYB003, the Company’s proprietary deuterated psilocin analog, in Phase 3 studies for the adjunctive treatment of major depressive […]

Economics

3 w. ago Elon Musk’s Neuralink brain chip clinical trial in Canada raises ethical questions

Some doctors and bioethicists are raising concerns about a Toronto hospital’s partnership with a company founded by U.S. billionaire Elon Musk. University Health Network announced earlier this month that two quadriplegic Canadian patients had received Musk’s Neuralink brain implants as part of a study testing the safety and effectiveness of the wireless device. While critics […]

Other

3 w. ago Health Canada approves Celltrion’s Stoboclo® and Osenvelt®(CT

Stoboclo® and Osenvelt® (CT-P41) received Health Canada Notice of Compliance for all indications referencing Prolia® and Xgeva®, respectively1,2 The approval is based on the totality of evidence including results from a Phase III clinical trial in postmenopausal women with osteoporosis (PMO)3 Celltrion’s biosimilar portfolio continues to grow, expanding treatment options to reach more patients in […]

Science

3 w. ago ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced Metastatic Cancer

TORONTO — ProteinQure, a Toronto-based biotech company pioneering computational peptide drug discovery, today announced the successful dosing of the first patient in its Phase I clinical trial evaluating PQ203 – a novel, rationally designed peptide therapeutic for advanced metastatic solid tumors. “Dosing our first patient with PQ203 represents a defining moment not just for ProteinQure, […]

Science

3 w. ago Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV

TEL AVIV, Israel, Sept. 16, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced plans to present data from the completed phase 3 SOLARIS trial at the 2025 Psych Congress Annual Meeting, taking place from September 17 – 21, 2025, in San Diego, California. Teva will also host a conference […]

Culture

4 w. ago Ferring Japan announces PMDA Acceptance of NDA Filing for nadofaragene firadenovec

Nadofaragene firadenovec is the first and only non-replicating gene therapy administered intravesically, and it is already approved and launched in the US This represents the first filing of a novel non-chemotherapy approach in non-muscle invasive bladder cancer (NMIBC) treatment In the Japanese Phase 3 clinical trial, 75% complete response rate was achieved with single quarterly […]

Other